Stryker shares plunge 12% on Q3 miss, weak guidance
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
Stryker reported third-quarter results that missed analyst expectations for adjusted earnings per share and revenue, sending shares down 12%. The medical technology company also set its full-year 2026 adjusted EPS guidance range below the consensus estimate. Management cited strong underlying business fundamentals and expected solid fourth-quarter performance with momentum into 2027. Investors face near-term pressure on lowered earnings expectations.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.